Screening for Hematology Branch Protocols

StatusEnrolling by Invitation
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 427 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fields
  2. Re-verified, no change to tracked fields
  3. Re-verified, no change to tracked fields
  4. Re-verified, no change to tracked fields
  5. Re-verified, no change to tracked fields
Show 45 earlier versionsHide 45 earlier versions
  1. Re-verified, no change to tracked fields
  2. Eligibility criteria expanded, about 1 word
  3. 16 versions Re-verified since Jul 7, 2026, no change to tracked fieldsv405-v420
  4. Study Status, Eligibility, Contacts/Locationsv404
  5. 26 versions Re-verified since Oct 10, 2025, no change to tracked fieldsv378-v403
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study allows the evaluation of subjects in order to determine their ability to safely participate in other active research studies. After subjects complete the screening process, they will be offered the opportunity to participate in an active research study, or if no appropriate studies are available information and recommendations will be provided for other treatment options.
Trial Details
NCT Number NCT00001620
Lead Sponsor National Heart, Lung, and Blood Institute (NHLBI)
Conditions
(from sponsor)		 Hematologic Disease and Disorders, Donors, Healthy Volunteer
Related terms Anemia, Cytopenia, Disease, Hematologic Diseases, Hematologic Neoplasms, Neutropenia, Thrombocytopenia
Enrollment 10,000 participants
Start Date
Updated on ClinicalTrials.gov